Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca loses comms head

Neil McCrae to join UK’s Royal Mail
AstraZeneca - Neil McCrae

AstraZeneca (AZ) has lost its VP of global communications to the UK's Royal Mail.

After almost two decades in the pharmaceutical sector, including six years with AZ, Neil McCrae will take up his new role on April 1.

Joining AstraZeneca in 2008 from GlaxoSmithKline (GSK), McCrae held a number of roles within the business, including vice-president of corporate communications and head of global media relations.

Prior to joining SmithKline Beecham, GSK's predecessor, in 1996, he part-owned the communications agency Design Publications.

"We wish Neil all the best in his new role,” said AstraZeneca's head of global media relations Esra Erkal-Paler.

Erkal-Paler said she was not yet able to say how AstraZeneca would place McCrae, or whether his departure would have any impact on the role of interim executive vice-president of human resources and corporate affairs Caroline Hempstead.

McCrae's remit at the Royal Mail will include media relations, internal communications, public affairs, corporate responsibility and community investment.

4th March 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics